DEMONSTRATION OF THE ANTIMYOCLONIC EFFECT OF 1-HYDROXY-3-AMINO-PYRROLIDONE-2 (HA-966) USING A NEW ANIMAL MODELMENON MK.1981; LIFE SCI. (1973); ISSN 0024-3205; GBR; DA. 1981; VOL. 28; NO 25; PP. 2865-2868; BIBL. 21 REF.Article

ASSAY OF HA-966 IN RAT PLASMA BY CAPILLARY GAS-LIQUID CHROMATOGRAPHY WITH NITROGEN-SELECTIVE DETECTIONBROXTERMAN HJ; NOACH EL; DE VOS D et al.1980; J. CHROMATOGR.; NLD; DA. 1980; VOL. 183; NO 2; PP. 185-191; BIBL. 9 REF.Article

Pharmacological agents, hippocampal EEG, and anticonvulsant effects on soman-induced seizures in ratsMYHRER, Trond; SKYMOEN, Leif Rune; AAS, Pal et al.Neurotoxicology (Park Forest South). 2003, Vol 24, Num 3, pp 357-367, issn 0161-813X, 11 p.Article

HA-966 (1-hydroxy-3-aminopyrrolidone-2) selectively reduces N-méthyl-D-aspartate (NMDA)-mediated brain damageMC DONALD, J. W; UCKELE, J; SILVERSTEIN, F. S et al.Neuroscience letters. 1989, Vol 104, Num 1-2, pp 167-170, issn 0304-3940Article

Blockade of the locomotor stimulant effects of cocaine and methamphetamine by glutamate antagonistsWITKIN, J. M.Life sciences (1973). 1993, Vol 53, Num 24, pp PL405-PL410, issn 0024-3205Article

Effects of HA-966 on conflict, social interaction, and plus maze behaviorsCORBETT, R; DUNN, R. W.Drug development research. 1991, Vol 24, Num 3, pp 201-205, issn 0272-4391Article

D-cycloserine blocks the effects of ethanol and HA-966 in rats tested in the elevated plus-mazeMORAES FERREIRA, V. M; STRUFFALDI MORATO, G.Alcoholism, clinical and experimental research. 1997, Vol 21, Num 9, pp 1638-1642, issn 0145-6008Article

ELECTRICAL STIMULATION OF THE NIGROSTRIATAL PATHWAY AFTER HA-966 BLOCK OF STRIATAL DOPAMINE RELEASE.VAN VALKENBURG CFM; NOACH EL.1978; EUROP. J. PHARMACOL.; NETHERL.; DA. 1978; VOL. 48; NO 2; PP. 171-177; BIBL. 1 P.Article

Effects on cocaine and food self-administration of (+)-HA-966, a partial agonist at the glycine/NMDA modulatory site, in ratsCERVO, Luigi; COCCO, Arianna; CARNOVALI, Francesco et al.Psychopharmacologia. 2004, Vol 173, Num 1-2, pp 124-131, issn 0033-3158, 8 p.Article

Etude des mécanismes de sensibilisation centrale et périphérique modulant l'action antinociceptive de la morphine au moyen de tests comportementaux dans les modèles animaux de douleurs inflammatoire et neuropathique = Study of central and peripheral mechanisms of sensitization modulating morphine antinociceptive effects with behavioral tests in animal models of neuropathic and inflammatory painPerrot, Serge; Kayser, Valerie.2001, 281 p.Thesis

Effects of the enantiomers of (±)-HA-966 on dopamine neurons : an electrophysiological study of a chiral moleculeSHEPARD, P. D; CONNELLY, S. T; LEHMANN, H et al.European journal of pharmacology. 1995, Vol 285, Num 1, pp 79-88, issn 0014-2999Article

R-(+)-HA-966, a glycine/NMDA receptor antagonist, selectively blocks the activation of the mesolimbic dopamine system by amphetamineHUTSON, P. H; BRISTOW, L. J; THORN, L et al.British journal of pharmacology. 1991, Vol 103, Num 4, pp 2037-2044, issn 0007-1188, 8 p.Article

In vivo antagonism of agonist actions at N-methyl-aspartate and N-methyl-D-aspartate-associated glycine receptors in mouse cerebellum : studies of 1-hydroxy-3-aminopyrrolidone-2WOOD, P. L; EMMETT, M. R; RAO, T. S et al.Neuropharmacology. 1990, Vol 29, Num 7, pp 675-679, issn 0028-3908, 5 p.Article

NMDA receptor antagonists that bind to the strychnine-insensitive glycine site and inhibit NMDA-induced Ca²⁺ fluxes and [³H]GABA releaseREYNOLDS, I. J; HARRIS, K. M; MILLER, R. J et al.European journal of pharmacology. 1989, Vol 172, Num 1, pp 9-17, issn 0014-2999Article

Comparative anterograde amnestic and anticonvulsant effects of two types of NMDA receptor antagonists : MK-801 and HA-966XIAOJUAN XU; KLINGER, P; DAVIS, R et al.Psychopharmacologia. 1995, Vol 117, Num 3, pp 333-339, issn 0033-3158Article

Anticonvulsant effects of the glycine/NMDA receptor ligands D-cycloserine and D-serine but not R-(+)-HA-966 in amygdala-kindled ratsLÖSCHER, W; WLAZ, P; RUNDFELDT, C et al.British journal of pharmacology. 1994, Vol 112, Num 1, pp 97-106, issn 0007-1188Article

Stereoselective by (R)-HA-966 of the binding of [³H]CPP to the NMDA receptor complexPULLAN, L. M; POWEL, R. J; STUMPO, R. J et al.European journal of pharmacology. 1990, Vol 189, Num 2-3, pp 237-240, issn 0014-2999, 4 p.Article

Repeated administration of HA-966 and haloperidol to rats: similar tolerance to striatal dopamine accumulation after HA-966 challenge, but dissimilar effects on striatal [³H]spiperone bindingVAN DER KROGT, J. A; VAN VALKENBURG, C. F. M; BELFROID, R. D. M et al.European journal of pharmacology. 1988, Vol 158, Num 1-2, pp 29-35, issn 0014-2999Article

Effects of D-cycloserine and (+)-HA-966 on the locomotor stimulation induced by NMDA antagonists and clonidine in monoamine-depleted miceCARLSSON, M. L; ENGBERG, G; CARLSSON, A et al.Journal of neural transmission. 1994, Vol 95, Num 3, pp 223-233, issn 0300-9564Article

Effects of and interactions between antagonists for different sites on the NMDA receptor complex on hippocampal and striatal acetylcholine efflux in vivoHUTSON, P. H; HOGG, J. E.European journal of pharmacology. 1996, Vol 295, Num 1, pp 45-52, issn 0014-2999Article

Anticonvulsant agents, dizocilpine maleate, enadoline and HA 966 have different effects on N-methyl-DL-aspartate-induced immediate early gene induction in miceWOODBURN, V. L; OLES, R; POAT, J et al.Neuroscience. 1993, Vol 56, Num 3, pp 703-709, issn 0306-4522Article

(±)-1-hydroxy-3-aminopyrrolidone-2(HA-966) inhibits the activity of substantia nigra dopamine neurons through a non-N-methyl-D-aspartate receptor-mediated mechanismSHEPARD, P. D; LEHMANN, H.The Journal of pharmacology and experimental therapeutics. 1992, Vol 261, Num 2, pp 387-394, issn 0022-3565Article

On central muscle relaxants, strychnine-insensitive glycine receptors and two old drugs : zoxazolamine and HA-966MCMILLEN, B. A; WILLIAMS, H. L; LEHMANN, H et al.Journal of neural transmission. 1992, Vol 89, Num 1-2, pp 11-25, issn 0300-9564Article

1-Hydroxy-3-aminopyrrolid-2-one (HA-966) and kynurenate antagonize N-methyl-D-aspartate induced enhancement of [³H]dopamine release from rat striatal slicesCRAWFORD, M; ROBERTS, P. J.Biochemical pharmacology. 1989, Vol 38, Num 23, pp 4165-4168, issn 0006-2952Article

Agonist-like character of the (R)-enantiomer of 1-hydroxy-3-amino-pyrrolid-2-one (HA-966)PULLAN, L. M; VERTICELLI, A. M; PASCHETTO, K. A et al.European journal of pharmacology. Molecular pharmacology section. 1991, Vol 208, Num 1, pp 25-29, issn 0922-4106Article